Rapid Medical Diagnostic Kits Market Size to Hit USD 67.0 Billion by 2035 | SNS Insider
Austin, United States, July 06, 2026 (GLOBE NEWSWIRE) -- The Rapid Medical Diagnostic Kits Market was valued at USD 28.11 Billion in 2025 and is expected to reach USD 67.0 Billion by 2035, growing at a CAGR of 9.06% from 2026–2035, according to a new report by SNS Insider.
The rapid medical diagnostic kits market is driven by increasing incidence of infections and chronic diseases and growing adoption of POCT technologies. According to WHO, there were about 1.3 million deaths caused by tuberculosis in 2022 and around 249 million malaria cases. Rapid diagnostic tests are the main screening tool in low-resource regions. Technological innovations in lateral flow assays and advanced biosensor-based diagnostics are enhancing speed and accuracy, while the growing preference for at-home testing and supportive government initiatives for rapid diagnostics are further driving market growth globally.
Get a Sample Copy of the Rapid Medical Diagnostic Kits Market Report 2026–2035 @ https://www.snsinsider.com/sample-request/6366
AI Diagnostics and Biosensor Innovations to Augment Market Expansion Globally
The rise of AI and biosensor-based diagnostic technologies enhances the accuracy and availability of the tests, creating new potential to increase the efficiency of rapid diagnostic kits having limited qualitative results. The connected health ecosystem is growing, and it’s a lucrative commercial opportunity for manufacturers. Rapid diagnostic kit results delivered into EHRs and remote patient monitoring systems are part of that ecosystem. Worldwide, there are more than 537 million adults with diabetes, which provides recurring testing revenue through all economic cycles worldwide.
Leading Market Players Listed in this Report are:
Segmentation Analysis:
By Product,
In 2025, the professional kits segment recorded the largest market share of 58% revenue owing to their wide usage in hospitals, clinics, and diagnostic laboratories that require high sensitivity, standardisation, and accuracy for disease diagnosis. The OTC kits are expected to register the highest CAGR during 2026–2035 due to increasing consumer demand for convenient self-testing products, growing awareness regarding early diagnosis, deep penetration of e-commerce, affordability and growing focus on preventive healthcare globally.
By Technology,
Lateral Flow dominated the market with 63% revenue share in 2025, owing to its simplicity, speed, low cost, and point-of-care diagnostics without the use of complex lab equipment in infectious disease screening and pregnancy testing. The solid phase is projected to record the highest CAGR during 2026–2035, due to the improved analytical performance, better sensitivity, and rising adoption in the field of advanced toxicology infection, and biomarker detection diagnostics across the globe.
By Application,
Infectious disease testing accounted for the largest share with 41% revenue in 2025, due to high global incidence of influenza, COVID-19, HIV and hepatitis requiring early detection, timely diagnosis and proper management across hospitals and emergency centres. The toxicology testing segment is anticipated to record the highest CAGR during the forecast period of 2026–2035, owing to growing concerns about substance abuse, health risks in the workplace, the need for forensic testing, and rapid progress in testing technologies worldwide.
By End-Use,
Diagnostic laboratories were the largest segment contributing 46% of revenue in 2025, supported by high testing capacity, advanced infrastructure and skilled labour handling large diagnostic sample volumes across major disease detection centres globally. Home care is expected to witness the highest CAGR during the forecast period 2026-2035, due to rising preference for self-diagnosis, increasing awareness about preventive healthcare, availability of easy-to-use kits and integration with digital health services across the globe.
Regional Insights:
North America held nearly 37% of the global rapid medical diagnostic kits market share, driven by advanced healthcare infrastructure, strong industry presence by Abbott, Becton Dickinson, and Quidel, and robust OTC adoption. The United States contributes to around 82.47% of the regional revenue. According to the CDC, influenza is responsible for about 9-41 million illnesses every year, which is fueling the continuous demand for rapid antigen testing.
The U.S. Rapid Medical Diagnostic Kits Market was valued at around USD 8.27 Billion in 2025 and is expected to reach around USD 16.32 Billion by 2035, growing at a CAGR of 7.85%. Growing consumer and practitioner acceptance of self-testing, combined with strong demand for digital glucose monitors, COVID-19 antigen kits, influenza diagnostics and multi-disease rapid test panels, is driving growth.
The Europe Rapid Medical Diagnostic Kits Market is expected to reach USD 8.80 Billion by 2025 and is projected to reach USD 18.10 Billion by 2035, at a CAGR of 7.49% during 2026-2035. The Europe market shows strong adoption of rapid diagnostic kits in Western European healthcare settings, with Germany alone accounting for about 28.47% of revenues in Europe due to its large pharmaceutical and healthcare infrastructure and complete public health insurance coverage enabling rapid diagnostic test reimbursement.
Asia Pacific is the fastest growing regional market and the growth is attributed to growing healthcare infrastructure and increasing awareness regarding early diagnosis across China, India and Japan. Augmented domestic manufacturing capacity and increased investment in healthcare infrastructure are driving China to contribute approximately 38.47% of Asia Pacific revenues.
Recent Developments:
Purchase the Rapid Medical Diagnostic Kits Market Report with Detailed Competitive Analysis and Forecast to 2035 @ https://www.snsinsider.com/checkout/6366
Exclusive Sections of the Report (The USPs):
Rapid Medical Diagnostic Kits Market Report Scope
Related Market Reports
Rapid Diagnostic Tests (RDT) Market Size, Share 2026
Rapid Tests Market Growth, Trends 2026
Point-of-Care Molecular Diagnostics Market Size, Outlook 2026
Point-of-Care Diagnostics Market Share, Analysis 2026
Point of Care Diagnostics/Testing Market Growth, Report 2026
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.